Organization
Lucence Health Inc
3 abstracts
Abstract
Liquid biopsy in combination with PET/CT versus PET/CT alone in diagnosis of lung cancer in small nodules.Org: VA Palo Alto Health Care System, Lucence Health Inc, Lucence Diagnostics Pte. Ltd., Lucence Diagnostics Pte Ltd, Palo Alto Veterans Institute for Research,
Abstract
Assessing the utility of liquid biopsy for detecting actionable genetic mutations among indigenous Ghanaian women with metastatic breast cancer.Org: Yemaachi Biotech, Cape Coast Teaching Hospital, University of Cape Coast, Lucence Diagnostics Pte Ltd, Lucence Health Inc,
Abstract
Longitudinal tracking of ALK-positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial.Org: University of Texas MD Anderson Cancer Center, MD Anderson Cancer Center, Lucence Health, Inc., Lucence Health Inc, Lucence Diagnostics Pte. Ltd.,